Almost two years into the pandemic, the scientific and healthcare communities continue to learn a great deal regarding COVID-19, the disease produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Broad variability during acute COVID-19 infection is seen, ranging from asymptomatic presentation to death. The vast majority of individuals who develop COVID-19 return to their pre-COVID-19 baseline within several weeks. However, a portion of patients will develop a post-COVID-19 syndrome of persistent cognitive, somatic, and behavioral symptoms. This syndrome, designated as post-acute sequelae of SARS-CoV-2 infection, is more commonly known as long COVID. The objectives of this paper are to inform psychologists regarding our current understanding of the underlying pathophysiology of COVID-19, review criteria for range of severity during acute illness, present clinical manifestations of long haul phenomena, and discuss the emerging literature base of evidence-based treatment and management approaches.
- Explain research current as of 2022 into the underlying pathophysiology of COVID-19.
- Describe the clinical manifestations of long haul phenomena.
- Analyze the emerging literature base of evidence-based treatment and management approaches.
Rivas-Vazquez, R. A., Rey, G., Quintana, A., and Rivas-Vazquez, A. A. (2022). Assessment and Management of Long COVID. Journal of Health Service Psychology, 48(1). https://doi.org/10.1007/s42843-022-00055-8